XML 14 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment Information
3 Months Ended
Mar. 31, 2012
Business Segment Information [Abstract]  
Business Segment Information

Note 2—Business segment information:

 

Business segment

  

Entity

   % controlled at
March  31, 2012
 

Chemicals

   Kronos      80

Component products

   CompX      87

Waste management

   WCS      100

Our control of Kronos includes 50% we hold directly and 30% held directly by NL. We own 83% of NL. Our control of CompX is through NL.

 

     Three months ended
March  31,
 
     2011     2012  
     (In millions)  

Net sales:

    

Chemicals

   $ 420.4      $ 561.3   

Component products

     34.8        35.5   

Waste management

     .5        1.1   
  

 

 

   

 

 

 

Total net sales

   $ 455.7      $ 597.9   
  

 

 

   

 

 

 

Cost of sales:

    

Chemicals

   $ 274.6      $ 300.4   

Component products

     26.1        26.0   

Waste management

     6.1        7.6   
  

 

 

   

 

 

 

Total cost of sales

   $ 306.8      $ 334.0   
  

 

 

   

 

 

 

Gross margin:

    

Chemicals

   $ 145.8      $ 260.9   

Component products

     8.7        9.5   

Waste management

     (5.6     (6.5
  

 

 

   

 

 

 

Total gross margin

   $ 148.9      $ 263.9   
  

 

 

   

 

 

 

 

     Three months ended
March  31,
 
     2011     2012  
     (In millions)  

Operating income (loss):

    

Chemicals

   $ 103.5      $ 211.3   

Component products

     8.8        2.9   

Waste management

     (9.0     (9.6
  

 

 

   

 

 

 

Total operating income

     103.3        204.6   

Equity in earnings of investee

     (.1     .1   

General corporate items:

    

Securities earnings

     7.4        7.1   

Insurance recoveries

     .4        1.1   

General expenses, net

     (6.6     (20.3

Loss on prepayment of debt

     (3.3     —     

Interest expense

     (17.2     (13.5
  

 

 

   

 

 

 

Income before income taxes

   $ 83.9      $ 179.1   
  

 

 

   

 

 

 

Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material. We received approximately $7.5 million for a patent litigation settlement in the first quarter of 2011, which is included in the determination of Component Products operating income, see Note 11.